There may soon be another COVID-19 vaccine on the market in the U.S. Novavax announced Monday that it has submitted a request to the Food and Drug Administration for emergency use authorization for ...
Novavax's updated vaccine will be available at vaccination centers across Taiwan In clinical trials, the most common adverse reactions associated with Novavax's prototype COVID-19 vaccine (NVX-CoV2373 ...
(RTTNews) - Novavax (NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovid to Sanofi (SNY), enabling Sanofi to take full responsibility for ...
Novavax, Inc., a Gaithersburg-based company advancing protein-based vaccines with its Matrix-M™ adjuvant, Tuesday announced its updated vaccine (Adjuvanted, 2024-2025 Formula, NVX-CoV2705) has ...
GAITHERSBURG, Md., Nov. 4, 2025 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX) has completed the transfer of the U.S. marketing authorization for its COVID-19 vaccine, Nuvaxovid™ to Sanofi, enabling ...
Novavax Inc (NASDAQ:NVAX) on Wednesday announced the receipt of European marketing authorization for its Nuvaxovid COVID-19 vaccine. What Happened: Novavax said the European Commission granted ...
(Reuters) -The European Commission authorized Novavax's updated COVID-19 vaccine targeting the JN.1 strain of coronavirus in the region, the company said on Wednesday. The authorization is for use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results